nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—CYP2E1—Parkinson's disease	0.381	1	CbGaD
Dalfampridine—KCNC3—brainstem—Parkinson's disease	0.00175	0.00653	CbGeAlD
Dalfampridine—KCNB1—forebrain—Parkinson's disease	0.00174	0.00649	CbGeAlD
Dalfampridine—KCNG3—cardiovascular system—Parkinson's disease	0.00171	0.00636	CbGeAlD
Dalfampridine—KCNA10—nervous system—Parkinson's disease	0.0017	0.00634	CbGeAlD
Dalfampridine—KCND1—embryo—Parkinson's disease	0.00169	0.00631	CbGeAlD
Dalfampridine—KCNA4—forebrain—Parkinson's disease	0.00165	0.00613	CbGeAlD
Dalfampridine—KCNA3—forebrain—Parkinson's disease	0.00165	0.00613	CbGeAlD
Dalfampridine—KCNA2—brainstem—Parkinson's disease	0.00162	0.00604	CbGeAlD
Dalfampridine—KCNG2—cerebellum—Parkinson's disease	0.0016	0.00596	CbGeAlD
Dalfampridine—KCNG4—head—Parkinson's disease	0.0016	0.00596	CbGeAlD
Dalfampridine—KCNH4—head—Parkinson's disease	0.0016	0.00596	CbGeAlD
Dalfampridine—KCNB2—head—Parkinson's disease	0.0016	0.00596	CbGeAlD
Dalfampridine—KCNA2—forebrain—Parkinson's disease	0.00157	0.00583	CbGeAlD
Dalfampridine—KCND1—brainstem—Parkinson's disease	0.00155	0.00578	CbGeAlD
Dalfampridine—KCNA1—hindbrain—Parkinson's disease	0.00155	0.00578	CbGeAlD
Dalfampridine—KCND3—hindbrain—Parkinson's disease	0.00154	0.00575	CbGeAlD
Dalfampridine—KCNB2—nervous system—Parkinson's disease	0.00152	0.00565	CbGeAlD
Dalfampridine—KCNG4—nervous system—Parkinson's disease	0.00152	0.00565	CbGeAlD
Dalfampridine—KCNH4—nervous system—Parkinson's disease	0.00152	0.00565	CbGeAlD
Dalfampridine—KCNC4—forebrain—Parkinson's disease	0.0015	0.00558	CbGeAlD
Dalfampridine—KCNC1—brainstem—Parkinson's disease	0.00149	0.00555	CbGeAlD
Dalfampridine—KCNB1—cardiovascular system—Parkinson's disease	0.00148	0.00549	CbGeAlD
Dalfampridine—KCNH5—head—Parkinson's disease	0.00146	0.00545	CbGeAlD
Dalfampridine—KCNB2—central nervous system—Parkinson's disease	0.00146	0.00544	CbGeAlD
Dalfampridine—KCNG4—central nervous system—Parkinson's disease	0.00146	0.00544	CbGeAlD
Dalfampridine—KCNH4—central nervous system—Parkinson's disease	0.00146	0.00544	CbGeAlD
Dalfampridine—KCNC1—forebrain—Parkinson's disease	0.00144	0.00536	CbGeAlD
Dalfampridine—KCNQ5—forebrain—Parkinson's disease	0.0014	0.00521	CbGeAlD
Dalfampridine—KCNA4—cardiovascular system—Parkinson's disease	0.00139	0.00518	CbGeAlD
Dalfampridine—KCNH5—nervous system—Parkinson's disease	0.00139	0.00516	CbGeAlD
Dalfampridine—KCNS2—head—Parkinson's disease	0.00136	0.00506	CbGeAlD
Dalfampridine—KCNA6—head—Parkinson's disease	0.00136	0.00506	CbGeAlD
Dalfampridine—KCNH5—central nervous system—Parkinson's disease	0.00134	0.00497	CbGeAlD
Dalfampridine—KCNH3—medulla oblongata—Parkinson's disease	0.0013	0.00484	CbGeAlD
Dalfampridine—KCNG2—brain—Parkinson's disease	0.0013	0.00484	CbGeAlD
Dalfampridine—KCNA6—nervous system—Parkinson's disease	0.00129	0.0048	CbGeAlD
Dalfampridine—KCNS2—nervous system—Parkinson's disease	0.00129	0.0048	CbGeAlD
Dalfampridine—KCNF1—forebrain—Parkinson's disease	0.00128	0.00478	CbGeAlD
Dalfampridine—KCNV1—head—Parkinson's disease	0.00128	0.00476	CbGeAlD
Dalfampridine—KCND1—cardiovascular system—Parkinson's disease	0.00127	0.00472	CbGeAlD
Dalfampridine—KCNH8—medulla oblongata—Parkinson's disease	0.00126	0.00469	CbGeAlD
Dalfampridine—KCNS2—central nervous system—Parkinson's disease	0.00124	0.00462	CbGeAlD
Dalfampridine—KCNA6—central nervous system—Parkinson's disease	0.00124	0.00462	CbGeAlD
Dalfampridine—KCNC1—cardiovascular system—Parkinson's disease	0.00122	0.00453	CbGeAlD
Dalfampridine—KCNV1—nervous system—Parkinson's disease	0.00121	0.00451	CbGeAlD
Dalfampridine—KCNV2—head—Parkinson's disease	0.00121	0.00451	CbGeAlD
Dalfampridine—KCNA4—medulla oblongata—Parkinson's disease	0.00119	0.00443	CbGeAlD
Dalfampridine—KCNV1—central nervous system—Parkinson's disease	0.00117	0.00435	CbGeAlD
Dalfampridine—KCNH3—spinal cord—Parkinson's disease	0.00116	0.00432	CbGeAlD
Dalfampridine—KCNB2—brain—Parkinson's disease	0.00116	0.00432	CbGeAlD
Dalfampridine—KCNG4—brain—Parkinson's disease	0.00116	0.00432	CbGeAlD
Dalfampridine—KCNH4—brain—Parkinson's disease	0.00116	0.00432	CbGeAlD
Dalfampridine—KCNC2—head—Parkinson's disease	0.00116	0.00431	CbGeAlD
Dalfampridine—KCNH1—head—Parkinson's disease	0.00116	0.00431	CbGeAlD
Dalfampridine—KCNG3—head—Parkinson's disease	0.00116	0.00431	CbGeAlD
Dalfampridine—KCNH8—midbrain—Parkinson's disease	0.00115	0.00429	CbGeAlD
Dalfampridine—KCNV2—nervous system—Parkinson's disease	0.00115	0.00428	CbGeAlD
Dalfampridine—KCNA5—forebrain—Parkinson's disease	0.00115	0.00427	CbGeAlD
Dalfampridine—KCNS1—medulla oblongata—Parkinson's disease	0.00113	0.00421	CbGeAlD
Dalfampridine—KCNQ3—forebrain—Parkinson's disease	0.00112	0.00418	CbGeAlD
Dalfampridine—KCNH8—spinal cord—Parkinson's disease	0.00112	0.00418	CbGeAlD
Dalfampridine—KCNV2—central nervous system—Parkinson's disease	0.00111	0.00412	CbGeAlD
Dalfampridine—KCNH1—nervous system—Parkinson's disease	0.0011	0.00408	CbGeAlD
Dalfampridine—KCNC2—nervous system—Parkinson's disease	0.0011	0.00408	CbGeAlD
Dalfampridine—KCNG3—nervous system—Parkinson's disease	0.0011	0.00408	CbGeAlD
Dalfampridine—KCNA4—midbrain—Parkinson's disease	0.00109	0.00405	CbGeAlD
Dalfampridine—KCNC4—medulla oblongata—Parkinson's disease	0.00108	0.00403	CbGeAlD
Dalfampridine—KCNQ2—brainstem—Parkinson's disease	0.00107	0.00399	CbGeAlD
Dalfampridine—KCNA3—spinal cord—Parkinson's disease	0.00106	0.00395	CbGeAlD
Dalfampridine—KCNH5—brain—Parkinson's disease	0.00106	0.00395	CbGeAlD
Dalfampridine—KCNH1—central nervous system—Parkinson's disease	0.00106	0.00393	CbGeAlD
Dalfampridine—KCNG3—central nervous system—Parkinson's disease	0.00106	0.00393	CbGeAlD
Dalfampridine—KCNC2—central nervous system—Parkinson's disease	0.00106	0.00393	CbGeAlD
Dalfampridine—KCNC1—medulla oblongata—Parkinson's disease	0.00104	0.00387	CbGeAlD
Dalfampridine—KCNS1—midbrain—Parkinson's disease	0.00103	0.00385	CbGeAlD
Dalfampridine—KCNA2—midbrain—Parkinson's disease	0.00103	0.00385	CbGeAlD
Dalfampridine—KCNQ2—forebrain—Parkinson's disease	0.00103	0.00385	CbGeAlD
Dalfampridine—KCNH1—cerebellum—Parkinson's disease	0.00103	0.00384	CbGeAlD
Dalfampridine—KCNH3—head—Parkinson's disease	0.00103	0.00384	CbGeAlD
Dalfampridine—KCNG1—head—Parkinson's disease	0.00103	0.00384	CbGeAlD
Dalfampridine—KCNH6—forebrain—Parkinson's disease	0.00103	0.00382	CbGeAlD
Dalfampridine—KCND2—brainstem—Parkinson's disease	0.00102	0.00378	CbGeAlD
Dalfampridine—KCNA2—spinal cord—Parkinson's disease	0.00101	0.00376	CbGeAlD
Dalfampridine—KCNH8—head—Parkinson's disease	0.000999	0.00372	CbGeAlD
Dalfampridine—KCNB1—head—Parkinson's disease	0.000999	0.00372	CbGeAlD
Dalfampridine—KCNC4—midbrain—Parkinson's disease	0.00099	0.00368	CbGeAlD
Dalfampridine—KCNA6—brain—Parkinson's disease	0.000986	0.00367	CbGeAlD
Dalfampridine—KCNS2—brain—Parkinson's disease	0.000986	0.00367	CbGeAlD
Dalfampridine—KCND2—forebrain—Parkinson's disease	0.00098	0.00365	CbGeAlD
Dalfampridine—KCNH3—nervous system—Parkinson's disease	0.000978	0.00364	CbGeAlD
Dalfampridine—KCNG1—nervous system—Parkinson's disease	0.000978	0.00364	CbGeAlD
Dalfampridine—KCNA5—cardiovascular system—Parkinson's disease	0.000971	0.00361	CbGeAlD
Dalfampridine—KCNC3—head—Parkinson's disease	0.00097	0.00361	CbGeAlD
Dalfampridine—KCNC1—midbrain—Parkinson's disease	0.000951	0.00354	CbGeAlD
Dalfampridine—KCNS3—cardiovascular system—Parkinson's disease	0.000951	0.00354	CbGeAlD
Dalfampridine—KCNQ3—cardiovascular system—Parkinson's disease	0.000951	0.00354	CbGeAlD
Dalfampridine—KCNB1—nervous system—Parkinson's disease	0.000947	0.00352	CbGeAlD
Dalfampridine—KCNH8—nervous system—Parkinson's disease	0.000947	0.00352	CbGeAlD
Dalfampridine—KCNA3—head—Parkinson's disease	0.000943	0.00351	CbGeAlD
Dalfampridine—KCNA4—head—Parkinson's disease	0.000943	0.00351	CbGeAlD
Dalfampridine—KCNH3—central nervous system—Parkinson's disease	0.000942	0.0035	CbGeAlD
Dalfampridine—KCNG1—central nervous system—Parkinson's disease	0.000942	0.0035	CbGeAlD
Dalfampridine—KCNC1—spinal cord—Parkinson's disease	0.000928	0.00345	CbGeAlD
Dalfampridine—KCNF1—medulla oblongata—Parkinson's disease	0.000927	0.00345	CbGeAlD
Dalfampridine—KCNV1—brain—Parkinson's disease	0.000927	0.00345	CbGeAlD
Dalfampridine—KCNQ5—midbrain—Parkinson's disease	0.000925	0.00344	CbGeAlD
Dalfampridine—KCNH3—cerebellum—Parkinson's disease	0.00092	0.00342	CbGeAlD
Dalfampridine—KCNG1—cerebellum—Parkinson's disease	0.00092	0.00342	CbGeAlD
Dalfampridine—KCNC3—nervous system—Parkinson's disease	0.000919	0.00342	CbGeAlD
Dalfampridine—KCNH8—central nervous system—Parkinson's disease	0.000912	0.00339	CbGeAlD
Dalfampridine—KCNB1—central nervous system—Parkinson's disease	0.000912	0.00339	CbGeAlD
Dalfampridine—KCNS1—head—Parkinson's disease	0.000897	0.00334	CbGeAlD
Dalfampridine—KCNA2—head—Parkinson's disease	0.000897	0.00334	CbGeAlD
Dalfampridine—KCNA4—nervous system—Parkinson's disease	0.000894	0.00333	CbGeAlD
Dalfampridine—KCNA3—nervous system—Parkinson's disease	0.000894	0.00333	CbGeAlD
Dalfampridine—KCNH8—cerebellum—Parkinson's disease	0.000891	0.00332	CbGeAlD
Dalfampridine—KCNA1—brainstem—Parkinson's disease	0.00089	0.00331	CbGeAlD
Dalfampridine—KCNC3—central nervous system—Parkinson's disease	0.000885	0.00329	CbGeAlD
Dalfampridine—KCND3—brainstem—Parkinson's disease	0.000885	0.00329	CbGeAlD
Dalfampridine—KCNV2—brain—Parkinson's disease	0.000879	0.00327	CbGeAlD
Dalfampridine—KCNC3—cerebellum—Parkinson's disease	0.000865	0.00322	CbGeAlD
Dalfampridine—KCNA4—central nervous system—Parkinson's disease	0.000861	0.0032	CbGeAlD
Dalfampridine—KCNA3—central nervous system—Parkinson's disease	0.000861	0.0032	CbGeAlD
Dalfampridine—KCNA1—forebrain—Parkinson's disease	0.000859	0.0032	CbGeAlD
Dalfampridine—KCND1—head—Parkinson's disease	0.000858	0.00319	CbGeAlD
Dalfampridine—KCNC4—head—Parkinson's disease	0.000858	0.00319	CbGeAlD
Dalfampridine—KCND3—forebrain—Parkinson's disease	0.000854	0.00318	CbGeAlD
Dalfampridine—KCNS1—nervous system—Parkinson's disease	0.000851	0.00317	CbGeAlD
Dalfampridine—KCNA2—nervous system—Parkinson's disease	0.000851	0.00317	CbGeAlD
Dalfampridine—KCNF1—midbrain—Parkinson's disease	0.000848	0.00315	CbGeAlD
Dalfampridine—KCNA4—cerebellum—Parkinson's disease	0.000842	0.00313	CbGeAlD
Dalfampridine—KCNA3—cerebellum—Parkinson's disease	0.000842	0.00313	CbGeAlD
Dalfampridine—KCNC2—brain—Parkinson's disease	0.000839	0.00312	CbGeAlD
Dalfampridine—KCNH1—brain—Parkinson's disease	0.000839	0.00312	CbGeAlD
Dalfampridine—KCNG3—brain—Parkinson's disease	0.000839	0.00312	CbGeAlD
Dalfampridine—KCNA5—medulla oblongata—Parkinson's disease	0.00083	0.00309	CbGeAlD
Dalfampridine—KCND2—cardiovascular system—Parkinson's disease	0.000829	0.00308	CbGeAlD
Dalfampridine—KCNF1—spinal cord—Parkinson's disease	0.000827	0.00308	CbGeAlD
Dalfampridine—KCNH7—head—Parkinson's disease	0.000825	0.00307	CbGeAlD
Dalfampridine—KCNC1—head—Parkinson's disease	0.000825	0.00307	CbGeAlD
Dalfampridine—KCNQ4—head—Parkinson's disease	0.000825	0.00307	CbGeAlD
Dalfampridine—KCNS1—central nervous system—Parkinson's disease	0.000819	0.00305	CbGeAlD
Dalfampridine—KCNA2—central nervous system—Parkinson's disease	0.000819	0.00305	CbGeAlD
Dalfampridine—KCNC4—nervous system—Parkinson's disease	0.000814	0.00303	CbGeAlD
Dalfampridine—KCND1—nervous system—Parkinson's disease	0.000814	0.00303	CbGeAlD
Dalfampridine—KCNS3—medulla oblongata—Parkinson's disease	0.000812	0.00302	CbGeAlD
Dalfampridine—KCNQ3—medulla oblongata—Parkinson's disease	0.000812	0.00302	CbGeAlD
Dalfampridine—KCNQ5—head—Parkinson's disease	0.000802	0.00298	CbGeAlD
Dalfampridine—KCNA2—cerebellum—Parkinson's disease	0.000801	0.00298	CbGeAlD
Dalfampridine—KCNC4—central nervous system—Parkinson's disease	0.000783	0.00292	CbGeAlD
Dalfampridine—KCND1—central nervous system—Parkinson's disease	0.000783	0.00292	CbGeAlD
Dalfampridine—KCNC1—nervous system—Parkinson's disease	0.000782	0.00291	CbGeAlD
Dalfampridine—KCNH7—nervous system—Parkinson's disease	0.000782	0.00291	CbGeAlD
Dalfampridine—KCNC4—cerebellum—Parkinson's disease	0.000766	0.00285	CbGeAlD
Dalfampridine—KCND1—cerebellum—Parkinson's disease	0.000766	0.00285	CbGeAlD
Dalfampridine—KCNQ5—nervous system—Parkinson's disease	0.000761	0.00283	CbGeAlD
Dalfampridine—KCNH7—central nervous system—Parkinson's disease	0.000753	0.0028	CbGeAlD
Dalfampridine—KCNC1—central nervous system—Parkinson's disease	0.000753	0.0028	CbGeAlD
Dalfampridine—KCNG1—brain—Parkinson's disease	0.000748	0.00278	CbGeAlD
Dalfampridine—KCNH3—brain—Parkinson's disease	0.000748	0.00278	CbGeAlD
Dalfampridine—KCNS3—midbrain—Parkinson's disease	0.000742	0.00276	CbGeAlD
Dalfampridine—KCNQ3—midbrain—Parkinson's disease	0.000742	0.00276	CbGeAlD
Dalfampridine—KCNA5—spinal cord—Parkinson's disease	0.00074	0.00275	CbGeAlD
Dalfampridine—KCNH7—cerebellum—Parkinson's disease	0.000736	0.00274	CbGeAlD
Dalfampridine—KCNQ4—cerebellum—Parkinson's disease	0.000736	0.00274	CbGeAlD
Dalfampridine—KCNC1—cerebellum—Parkinson's disease	0.000736	0.00274	CbGeAlD
Dalfampridine—KCNF1—head—Parkinson's disease	0.000735	0.00273	CbGeAlD
Dalfampridine—KCNQ5—central nervous system—Parkinson's disease	0.000732	0.00272	CbGeAlD
Dalfampridine—KCNS3—spinal cord—Parkinson's disease	0.000724	0.0027	CbGeAlD
Dalfampridine—KCNB1—brain—Parkinson's disease	0.000724	0.00269	CbGeAlD
Dalfampridine—KCNH8—brain—Parkinson's disease	0.000724	0.00269	CbGeAlD
Dalfampridine—KCND3—cardiovascular system—Parkinson's disease	0.000722	0.00269	CbGeAlD
Dalfampridine—KCND2—medulla oblongata—Parkinson's disease	0.000708	0.00263	CbGeAlD
Dalfampridine—KCNC3—brain—Parkinson's disease	0.000703	0.00262	CbGeAlD
Dalfampridine—KCNQ1—cardiovascular system—Parkinson's disease	0.000699	0.0026	CbGeAlD
Dalfampridine—KCNF1—nervous system—Parkinson's disease	0.000697	0.00259	CbGeAlD
Dalfampridine—KCNA4—brain—Parkinson's disease	0.000684	0.00254	CbGeAlD
Dalfampridine—KCNA3—brain—Parkinson's disease	0.000684	0.00254	CbGeAlD
Dalfampridine—KCNF1—central nervous system—Parkinson's disease	0.000671	0.0025	CbGeAlD
Dalfampridine—KCNA5—head—Parkinson's disease	0.000657	0.00245	CbGeAlD
Dalfampridine—KCNF1—cerebellum—Parkinson's disease	0.000656	0.00244	CbGeAlD
Dalfampridine—KCNA2—brain—Parkinson's disease	0.00065	0.00242	CbGeAlD
Dalfampridine—KCNS1—brain—Parkinson's disease	0.00065	0.00242	CbGeAlD
Dalfampridine—KCND2—midbrain—Parkinson's disease	0.000647	0.00241	CbGeAlD
Dalfampridine—KCNS3—head—Parkinson's disease	0.000644	0.0024	CbGeAlD
Dalfampridine—KCNQ3—head—Parkinson's disease	0.000644	0.0024	CbGeAlD
Dalfampridine—KCND2—spinal cord—Parkinson's disease	0.000631	0.00235	CbGeAlD
Dalfampridine—KCNA5—nervous system—Parkinson's disease	0.000623	0.00232	CbGeAlD
Dalfampridine—KCND1—brain—Parkinson's disease	0.000622	0.00231	CbGeAlD
Dalfampridine—KCNC4—brain—Parkinson's disease	0.000622	0.00231	CbGeAlD
Dalfampridine—KCNQ3—nervous system—Parkinson's disease	0.00061	0.00227	CbGeAlD
Dalfampridine—KCNA5—central nervous system—Parkinson's disease	0.0006	0.00223	CbGeAlD
Dalfampridine—KCNQ1—medulla oblongata—Parkinson's disease	0.000598	0.00222	CbGeAlD
Dalfampridine—KCNH7—brain—Parkinson's disease	0.000598	0.00222	CbGeAlD
Dalfampridine—KCNC1—brain—Parkinson's disease	0.000598	0.00222	CbGeAlD
Dalfampridine—KCNQ4—brain—Parkinson's disease	0.000598	0.00222	CbGeAlD
Dalfampridine—KCNQ2—head—Parkinson's disease	0.000592	0.0022	CbGeAlD
Dalfampridine—KCNQ3—central nervous system—Parkinson's disease	0.000588	0.00219	CbGeAlD
Dalfampridine—KCNH6—head—Parkinson's disease	0.000588	0.00219	CbGeAlD
Dalfampridine—KCNQ5—brain—Parkinson's disease	0.000581	0.00216	CbGeAlD
Dalfampridine—KCNQ3—cerebellum—Parkinson's disease	0.000574	0.00214	CbGeAlD
Dalfampridine—KCNA1—midbrain—Parkinson's disease	0.000567	0.00211	CbGeAlD
Dalfampridine—KCND3—midbrain—Parkinson's disease	0.000564	0.0021	CbGeAlD
Dalfampridine—KCNQ2—nervous system—Parkinson's disease	0.000562	0.00209	CbGeAlD
Dalfampridine—KCND2—head—Parkinson's disease	0.000561	0.00209	CbGeAlD
Dalfampridine—KCNH6—nervous system—Parkinson's disease	0.000557	0.00207	CbGeAlD
Dalfampridine—KCNA1—spinal cord—Parkinson's disease	0.000553	0.00206	CbGeAlD
Dalfampridine—KCNQ2—central nervous system—Parkinson's disease	0.000541	0.00201	CbGeAlD
Dalfampridine—KCNH6—central nervous system—Parkinson's disease	0.000536	0.002	CbGeAlD
Dalfampridine—KCNF1—brain—Parkinson's disease	0.000533	0.00198	CbGeAlD
Dalfampridine—KCND2—nervous system—Parkinson's disease	0.000532	0.00198	CbGeAlD
Dalfampridine—KCNQ2—cerebellum—Parkinson's disease	0.000529	0.00197	CbGeAlD
Dalfampridine—KCND2—central nervous system—Parkinson's disease	0.000512	0.00191	CbGeAlD
Dalfampridine—KCND2—cerebellum—Parkinson's disease	0.000501	0.00186	CbGeAlD
Dalfampridine—KCNA1—head—Parkinson's disease	0.000492	0.00183	CbGeAlD
Dalfampridine—KCND3—head—Parkinson's disease	0.000489	0.00182	CbGeAlD
Dalfampridine—KCNA5—brain—Parkinson's disease	0.000476	0.00177	CbGeAlD
Dalfampridine—KCNQ1—head—Parkinson's disease	0.000474	0.00176	CbGeAlD
Dalfampridine—KCNS3—brain—Parkinson's disease	0.000467	0.00174	CbGeAlD
Dalfampridine—KCNQ3—brain—Parkinson's disease	0.000467	0.00174	CbGeAlD
Dalfampridine—KCNA1—nervous system—Parkinson's disease	0.000466	0.00173	CbGeAlD
Dalfampridine—KCND3—nervous system—Parkinson's disease	0.000464	0.00173	CbGeAlD
Dalfampridine—KCNA1—central nervous system—Parkinson's disease	0.000449	0.00167	CbGeAlD
Dalfampridine—KCND3—central nervous system—Parkinson's disease	0.000446	0.00166	CbGeAlD
Dalfampridine—KCNA1—cerebellum—Parkinson's disease	0.000439	0.00163	CbGeAlD
Dalfampridine—KCND3—cerebellum—Parkinson's disease	0.000436	0.00162	CbGeAlD
Dalfampridine—KCNQ2—brain—Parkinson's disease	0.000429	0.0016	CbGeAlD
Dalfampridine—KCNH6—brain—Parkinson's disease	0.000426	0.00158	CbGeAlD
Dalfampridine—KCND2—brain—Parkinson's disease	0.000407	0.00151	CbGeAlD
Dalfampridine—KCNA1—brain—Parkinson's disease	0.000356	0.00133	CbGeAlD
Dalfampridine—KCND3—brain—Parkinson's disease	0.000354	0.00132	CbGeAlD
Dalfampridine—KCNQ1—brain—Parkinson's disease	0.000343	0.00128	CbGeAlD
Dalfampridine—KCNH2—forebrain—Parkinson's disease	0.000315	0.00117	CbGeAlD
Dalfampridine—KCNH2—cardiovascular system—Parkinson's disease	0.000267	0.000992	CbGeAlD
Dalfampridine—KCNH2—medulla oblongata—Parkinson's disease	0.000228	0.000848	CbGeAlD
Dalfampridine—KCNH2—midbrain—Parkinson's disease	0.000208	0.000775	CbGeAlD
Dalfampridine—CYP2E1—cardiovascular system—Parkinson's disease	0.000205	0.000764	CbGeAlD
Dalfampridine—KCNH2—spinal cord—Parkinson's disease	0.000203	0.000756	CbGeAlD
Dalfampridine—KCNH2—head—Parkinson's disease	0.000181	0.000672	CbGeAlD
Dalfampridine—CYP2E1—medulla oblongata—Parkinson's disease	0.000175	0.000653	CbGeAlD
Dalfampridine—KCNH2—nervous system—Parkinson's disease	0.000171	0.000637	CbGeAlD
Dalfampridine—KCNH2—central nervous system—Parkinson's disease	0.000165	0.000613	CbGeAlD
Dalfampridine—KCNH2—cerebellum—Parkinson's disease	0.000161	0.000599	CbGeAlD
Dalfampridine—CYP2E1—spinal cord—Parkinson's disease	0.000156	0.000582	CbGeAlD
Dalfampridine—KCNC2—Metabolism—ND3—Parkinson's disease	0.000141	0.000403	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MCCC1—Parkinson's disease	0.000141	0.000403	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—COMT—Parkinson's disease	0.00014	0.0004	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—MAOA—Parkinson's disease	0.000139	0.000397	CbGpPWpGaD
Dalfampridine—CYP2E1—head—Parkinson's disease	0.000139	0.000517	CbGeAlD
Dalfampridine—KCNA1—Neuronal System—DLG4—Parkinson's disease	0.000139	0.000396	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000138	0.000394	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—DLG4—Parkinson's disease	0.000137	0.000391	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—GRIN2B—Parkinson's disease	0.000136	0.000387	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—CHRNA4—Parkinson's disease	0.000135	0.000386	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—CHRNA4—Parkinson's disease	0.000135	0.000386	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MCCC1—Parkinson's disease	0.000134	0.000382	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ND3—Parkinson's disease	0.000134	0.000382	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—SLC6A3—Parkinson's disease	0.000134	0.000382	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—GRIN2B—Parkinson's disease	0.000134	0.000382	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—OMD—Parkinson's disease	0.000133	0.000379	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TALDO1—Parkinson's disease	0.000133	0.000379	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TALDO1—Parkinson's disease	0.000133	0.000379	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TALDO1—Parkinson's disease	0.000133	0.000379	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—OMD—Parkinson's disease	0.000133	0.000379	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—OMD—Parkinson's disease	0.000133	0.000379	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—DLG1—Parkinson's disease	0.000132	0.000377	CbGpPWpGaD
Dalfampridine—CYP2E1—nervous system—Parkinson's disease	0.000132	0.000491	CbGeAlD
Dalfampridine—KCNH7—Neuronal System—SLC6A3—Parkinson's disease	0.000132	0.000376	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—GDNF—Parkinson's disease	0.000131	0.000375	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—GDNF—Parkinson's disease	0.000131	0.000375	CbGpPWpGaD
Dalfampridine—KCNH2—brain—Parkinson's disease	0.000131	0.000487	CbGeAlD
Dalfampridine—KCND2—Neuronal System—COMT—Parkinson's disease	0.000128	0.000366	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—COMT—Parkinson's disease	0.000128	0.000366	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—MAOA—Parkinson's disease	0.000127	0.000363	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—MAOA—Parkinson's disease	0.000127	0.000363	CbGpPWpGaD
Dalfampridine—CYP2E1—central nervous system—Parkinson's disease	0.000127	0.000472	CbGeAlD
Dalfampridine—KCNB1—Metabolism—TALDO1—Parkinson's disease	0.000126	0.000359	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—OMD—Parkinson's disease	0.000126	0.000359	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NDUFB11—Parkinson's disease	0.000126	0.000359	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NDUFB11—Parkinson's disease	0.000126	0.000359	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NDUFB11—Parkinson's disease	0.000126	0.000359	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—COMT—Parkinson's disease	0.000126	0.000359	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—MAOA—Parkinson's disease	0.000125	0.000356	CbGpPWpGaD
Dalfampridine—CYP2E1—cerebellum—Parkinson's disease	0.000124	0.000462	CbGeAlD
Dalfampridine—KCNQ2—Neuronal System—HSPA8—Parkinson's disease	0.000124	0.000354	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HSPA8—Parkinson's disease	0.000124	0.000354	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GCH1—Parkinson's disease	0.00012	0.000343	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GCH1—Parkinson's disease	0.00012	0.000343	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GCH1—Parkinson's disease	0.00012	0.000343	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NDUFB11—Parkinson's disease	0.000119	0.000341	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—DLG4—Parkinson's disease	0.000116	0.000332	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—DLG4—Parkinson's disease	0.000116	0.000332	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GCH1—Parkinson's disease	0.000114	0.000325	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—COMT—Parkinson's disease	0.000114	0.000325	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—GRIN2B—Parkinson's disease	0.000114	0.000325	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—GRIN2B—Parkinson's disease	0.000114	0.000325	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—MAOA—Parkinson's disease	0.000113	0.000322	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—COMT—Parkinson's disease	0.000112	0.00032	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—SLC6A3—Parkinson's disease	0.000112	0.00032	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—SLC6A3—Parkinson's disease	0.000112	0.00032	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—MAOA—Parkinson's disease	0.000111	0.000318	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HSPA8—Parkinson's disease	0.00011	0.000314	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HSPA8—Parkinson's disease	0.00011	0.000314	CbGpPWpGaD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000109	0.000311	CbGpPWpGaD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—Parkinson's disease	0.000108	0.000307	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000107	0.000306	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—FBP1—Parkinson's disease	0.000107	0.000305	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—DBH—Parkinson's disease	0.000107	0.000305	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GBA—Parkinson's disease	0.000107	0.000305	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GBA—Parkinson's disease	0.000107	0.000305	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—DBH—Parkinson's disease	0.000107	0.000305	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GBA—Parkinson's disease	0.000107	0.000305	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—FBP1—Parkinson's disease	0.000107	0.000305	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—FBP1—Parkinson's disease	0.000107	0.000305	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—DBH—Parkinson's disease	0.000107	0.000305	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000106	0.000302	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—GRIK1—Parkinson's disease	0.000103	0.000295	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—DLG4—Parkinson's disease	0.000103	0.000295	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—DLG4—Parkinson's disease	0.000103	0.000295	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000103	0.000295	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000102	0.00029	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—FBP1—Parkinson's disease	0.000101	0.00029	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GBA—Parkinson's disease	0.000101	0.00029	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—DBH—Parkinson's disease	0.000101	0.00029	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—GRIN2B—Parkinson's disease	0.000101	0.000288	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—GRIN2B—Parkinson's disease	0.000101	0.000288	CbGpPWpGaD
Dalfampridine—CYP2E1—brain—Parkinson's disease	0.000101	0.000375	CbGeAlD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	9.79e-05	0.00028	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	9.77e-05	0.000279	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	9.69e-05	0.000277	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	9.56e-05	0.000273	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—COMT—Parkinson's disease	9.52e-05	0.000272	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—COMT—Parkinson's disease	9.52e-05	0.000272	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—MAOA—Parkinson's disease	9.46e-05	0.00027	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—MAOA—Parkinson's disease	9.46e-05	0.00027	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TH—Parkinson's disease	8.88e-05	0.000254	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—GRIK2—Parkinson's disease	8.78e-05	0.000251	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—SLC18A2—Parkinson's disease	8.51e-05	0.000243	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—ABL1—Parkinson's disease	8.22e-05	0.000235	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ABL1—Parkinson's disease	8.22e-05	0.000235	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	7.86e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—DDC—Parkinson's disease	7.85e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—DDC—Parkinson's disease	7.85e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—DDC—Parkinson's disease	7.85e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HSPA8—Parkinson's disease	7.85e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HSPA8—Parkinson's disease	7.85e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	7.5e-05	0.000214	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—DDC—Parkinson's disease	7.44e-05	0.000213	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTA4—Parkinson's disease	7.41e-05	0.000212	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTA4—Parkinson's disease	7.41e-05	0.000212	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTA4—Parkinson's disease	7.41e-05	0.000212	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—DLG4—Parkinson's disease	7.36e-05	0.00021	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—DLG4—Parkinson's disease	7.36e-05	0.00021	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—MAPK8—Parkinson's disease	7.33e-05	0.000209	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	7.24e-05	0.000207	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—GRIN2B—Parkinson's disease	7.2e-05	0.000205	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—GRIN2B—Parkinson's disease	7.2e-05	0.000205	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	7.1e-05	0.000203	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTA4—Parkinson's disease	7.03e-05	0.000201	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—CHRNA4—Parkinson's disease	6.73e-05	0.000192	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PLA2G6—Parkinson's disease	6.68e-05	0.000191	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PLA2G6—Parkinson's disease	6.68e-05	0.000191	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PLA2G6—Parkinson's disease	6.68e-05	0.000191	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MAOB—Parkinson's disease	6.61e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MAOB—Parkinson's disease	6.61e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MAOB—Parkinson's disease	6.61e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—NGF—Parkinson's disease	6.42e-05	0.000183	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—MAPK8—Parkinson's disease	6.41e-05	0.000183	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PLA2G6—Parkinson's disease	6.33e-05	0.000181	CbGpPWpGaD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—Parkinson's disease	6.3e-05	0.00018	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTA4—Parkinson's disease	6.3e-05	0.00018	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MAOB—Parkinson's disease	6.26e-05	0.000179	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTA4—Parkinson's disease	6.21e-05	0.000177	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HSPA8—Parkinson's disease	6.17e-05	0.000176	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	6.11e-05	0.000175	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	5.91e-05	0.000169	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ABL1—Parkinson's disease	5.87e-05	0.000168	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ABL1—Parkinson's disease	5.87e-05	0.000168	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—DLG4—Parkinson's disease	5.79e-05	0.000165	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.73e-05	0.000164	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—GRIN2B—Parkinson's disease	5.66e-05	0.000162	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—MAOB—Parkinson's disease	5.61e-05	0.00016	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—SLC6A3—Parkinson's disease	5.58e-05	0.000159	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP2D6—Parkinson's disease	4.91e-05	0.00014	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP2D6—Parkinson's disease	4.91e-05	0.00014	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP2D6—Parkinson's disease	4.91e-05	0.00014	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CTGF—Parkinson's disease	4.82e-05	0.000138	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CTGF—Parkinson's disease	4.82e-05	0.000138	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CTGF—Parkinson's disease	4.82e-05	0.000138	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—COMT—Parkinson's disease	4.74e-05	0.000135	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MAOA—Parkinson's disease	4.71e-05	0.000134	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—IL6—Parkinson's disease	4.68e-05	0.000134	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP2D6—Parkinson's disease	4.66e-05	0.000133	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CTGF—Parkinson's disease	4.57e-05	0.000131	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP2E1—Parkinson's disease	4.49e-05	0.000128	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP2E1—Parkinson's disease	4.49e-05	0.000128	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP2E1—Parkinson's disease	4.49e-05	0.000128	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NQO1—Parkinson's disease	4.44e-05	0.000127	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NQO1—Parkinson's disease	4.44e-05	0.000127	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NQO1—Parkinson's disease	4.44e-05	0.000127	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TH—Parkinson's disease	4.38e-05	0.000125	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TH—Parkinson's disease	4.38e-05	0.000125	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TH—Parkinson's disease	4.38e-05	0.000125	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP2E1—Parkinson's disease	4.26e-05	0.000122	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NQO1—Parkinson's disease	4.21e-05	0.00012	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYCS—Parkinson's disease	4.2e-05	0.00012	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYCS—Parkinson's disease	4.2e-05	0.00012	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYCS—Parkinson's disease	4.2e-05	0.00012	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP2D6—Parkinson's disease	4.17e-05	0.000119	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TH—Parkinson's disease	4.15e-05	0.000119	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP2D6—Parkinson's disease	4.12e-05	0.000118	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—IL6—Parkinson's disease	4.09e-05	0.000117	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYCS—Parkinson's disease	3.98e-05	0.000114	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—INS—Parkinson's disease	3.88e-05	0.000111	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—INS—Parkinson's disease	3.88e-05	0.000111	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—COMT—Parkinson's disease	3.72e-05	0.000106	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—COMT—Parkinson's disease	3.72e-05	0.000106	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—COMT—Parkinson's disease	3.72e-05	0.000106	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTP1—Parkinson's disease	3.7e-05	0.000106	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTP1—Parkinson's disease	3.7e-05	0.000106	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTP1—Parkinson's disease	3.7e-05	0.000106	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MAOA—Parkinson's disease	3.7e-05	0.000106	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MAOA—Parkinson's disease	3.7e-05	0.000106	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MAOA—Parkinson's disease	3.7e-05	0.000106	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HMOX1—Parkinson's disease	3.65e-05	0.000104	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HMOX1—Parkinson's disease	3.65e-05	0.000104	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HMOX1—Parkinson's disease	3.65e-05	0.000104	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	3.62e-05	0.000103	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	3.61e-05	0.000103	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—COMT—Parkinson's disease	3.53e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTP1—Parkinson's disease	3.51e-05	0.0001	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCB1—Parkinson's disease	3.51e-05	0.0001	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCB1—Parkinson's disease	3.51e-05	0.0001	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCB1—Parkinson's disease	3.51e-05	0.0001	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MAOA—Parkinson's disease	3.5e-05	0.0001	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HMOX1—Parkinson's disease	3.46e-05	9.89e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTM1—Parkinson's disease	3.4e-05	9.72e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTM1—Parkinson's disease	3.4e-05	9.72e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTM1—Parkinson's disease	3.4e-05	9.72e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCB1—Parkinson's disease	3.32e-05	9.49e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GPX1—Parkinson's disease	3.26e-05	9.31e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GPX1—Parkinson's disease	3.26e-05	9.31e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GPX1—Parkinson's disease	3.26e-05	9.31e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTM1—Parkinson's disease	3.23e-05	9.22e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—COMT—Parkinson's disease	3.16e-05	9.03e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTP1—Parkinson's disease	3.15e-05	8.99e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—MAOA—Parkinson's disease	3.14e-05	8.97e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—COMT—Parkinson's disease	3.12e-05	8.91e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTP1—Parkinson's disease	3.1e-05	8.86e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GPX1—Parkinson's disease	3.09e-05	8.83e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MTHFR—Parkinson's disease	3.01e-05	8.59e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MTHFR—Parkinson's disease	3.01e-05	8.59e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MTHFR—Parkinson's disease	3.01e-05	8.59e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTM1—Parkinson's disease	2.89e-05	8.26e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTM1—Parkinson's disease	2.85e-05	8.15e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTHFR—Parkinson's disease	2.85e-05	8.14e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOE—Parkinson's disease	2.8e-05	8e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOE—Parkinson's disease	2.8e-05	8e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOE—Parkinson's disease	2.8e-05	8e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOE—Parkinson's disease	2.66e-05	7.58e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	2.63e-05	7.51e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—INS—Parkinson's disease	2.39e-05	6.83e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—INS—Parkinson's disease	2.39e-05	6.83e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—INS—Parkinson's disease	2.39e-05	6.83e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—Parkinson's disease	2.37e-05	6.78e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—Parkinson's disease	2.37e-05	6.78e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—INS—Parkinson's disease	2.27e-05	6.48e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.12e-05	6.06e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—Parkinson's disease	2.1e-05	5.99e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—Parkinson's disease	2.1e-05	5.99e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ND3—Parkinson's disease	2.05e-05	5.86e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MCCC1—Parkinson's disease	2.05e-05	5.86e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TALDO1—Parkinson's disease	1.93e-05	5.51e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—OMD—Parkinson's disease	1.93e-05	5.51e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	1.83e-05	5.22e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GCH1—Parkinson's disease	1.74e-05	4.98e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—Parkinson's disease	1.69e-05	4.84e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—Parkinson's disease	1.69e-05	4.84e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DBH—Parkinson's disease	1.55e-05	4.44e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FBP1—Parkinson's disease	1.55e-05	4.44e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GBA—Parkinson's disease	1.55e-05	4.44e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DDC—Parkinson's disease	1.14e-05	3.26e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA4—Parkinson's disease	1.08e-05	3.08e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	9.7e-06	2.77e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MAOB—Parkinson's disease	9.6e-06	2.74e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	7.14e-06	2.04e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CTGF—Parkinson's disease	7e-06	2e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NQO1—Parkinson's disease	6.45e-06	1.84e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TH—Parkinson's disease	6.36e-06	1.82e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYCS—Parkinson's disease	6.11e-06	1.74e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—COMT—Parkinson's disease	5.41e-06	1.54e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTP1—Parkinson's disease	5.38e-06	1.54e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MAOA—Parkinson's disease	5.37e-06	1.53e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMOX1—Parkinson's disease	5.31e-06	1.52e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCB1—Parkinson's disease	5.1e-06	1.45e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM1—Parkinson's disease	4.95e-06	1.41e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPX1—Parkinson's disease	4.74e-06	1.35e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTHFR—Parkinson's disease	4.37e-06	1.25e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOE—Parkinson's disease	4.07e-06	1.16e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—INS—Parkinson's disease	3.48e-06	9.93e-06	CbGpPWpGaD
